Rhythm Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Rhythm Pharmaceutical (RYTM) IPO Opens Up 37%
October 5, 2017 10:59 AM EDTToday's IPO for Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) opened for trading at $23.21 after pricing 7,050,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts.
In addition, Rhythm has granted the underwriters a 30-day option to purchase up to... More
